Zymeworks shareholder EcoR1 Capital disclosed in a regulatory filing that it had purchased 1,026,300 shares of Zymeworks at $7.67 per share between January 10 and January 11 for a total transaction amount of $7,874,081.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ZYME:
- Zymeworks (NASDAQ:ZYME) Stock: Insider Buys Shares Worth $8M
- Zymeworks says well positioned to enhance shareholder value
- Zymeworks sees FY23 cash burn of $90M-$120M, can fund operations through FY26
- H.C. Wainwright keeps Neutral on Zymeworks, lowers price target to $8
- Zymeworks price target raised to $9 from $7 at Barclays